These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32743638)

  • 1. β-Lactamase-Producing, Ciprofloxacin-Resistant Neisseria meningitidis Isolated From a 5-Month-Old Boy in the United States.
    Taormina G; Campos J; Sweitzer J; Retchless AC; Lunquest K; McNamara LA; Reese N; Karlsson M; Hanisch B
    J Pediatric Infect Dis Soc; 2021 Apr; 10(3):379-381. PubMed ID: 32743638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquisition of Ciprofloxacin Resistance Among an Expanding Clade of β-Lactamase-Positive, Serogroup Y Neisseria meningitidis in the United States.
    Potts CC; Retchless AC; McNamara LA; Marasini D; Reese N; Swint S; Hu F; Sharma S; Blain AE; Lonsway D; Karlsson M; Hariri S; Fox LM; Wang X;
    Clin Infect Dis; 2021 Oct; 73(7):1185-1193. PubMed ID: 33900407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Ciprofloxacin-Resistant, β-Lactamase-Producing Neisseria meningitidis Serogroup Y Isolates - United States, 2019-2020.
    McNamara LA; Potts C; Blain AE; Retchless AC; Reese N; Swint S; Lonsway D; Karlsson M; Lunquest K; Sweitzer JJ; Wang X; Hariri S; Fox LM;
    MMWR Morb Mortal Wkly Rep; 2020 Jun; 69(24):735-739. PubMed ID: 32555137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penicillin- and Ciprofloxacin-Resistant Invasive Neisseria meningitidis Isolates from Japan.
    Saito R; Nakajima J; Prah I; Morita M; Mahazu S; Ota Y; Kobayashi A; Tohda S; Kamiya H; Takahashi H; Ohnishi M
    Microbiol Spectr; 2022 Jun; 10(3):e0062722. PubMed ID: 35467371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America.
    Wu HM; Harcourt BH; Hatcher CP; Wei SC; Novak RT; Wang X; Juni BA; Glennen A; Boxrud DJ; Rainbow J; Schmink S; Mair RD; Theodore MJ; Sander MA; Miller TK; Kruger K; Cohn AC; Clark TA; Messonnier NE; Mayer LW; Lynfield R
    N Engl J Med; 2009 Feb; 360(9):886-92. PubMed ID: 19246360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive meningococcal disease due to ciprofloxacin-resistant Neisseria meningitidis sequence type 4821: The first case in Japan.
    Kawasaki Y; Matsubara K; Takahashi H; Morita M; Ohnishi M; Hori M; Isome K; Iwata A; Nigami H; Ikemachi M; Yamamoto G; Ohkusu K
    J Infect Chemother; 2018 Apr; 24(4):305-308. PubMed ID: 29233459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mismatch amplification mutation assay for specific detection of ciprofloxacin-resistant Neisseria meningitidis.
    Ota Y; Okada R; Takahashi H; Saito R
    J Infect Chemother; 2023 May; 29(5):562-564. PubMed ID: 36758676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of Antibiotics as Prophylaxis for Close Contacts of Patients with Meningococcal Disease in Areas with Ciprofloxacin Resistance - United States, 2024.
    Berry I; Rubis AB; Howie RL; Sharma S; Marasini D; Marjuki H; Crowe S; McNamara LA
    MMWR Morb Mortal Wkly Rep; 2024 Feb; 73(5):99-103. PubMed ID: 38329923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penicillin-resistant Neisseria meningitidis bacteraemia, Kimberley region, March 2010.
    Abeysuriya SD; Speers DJ; Gardiner J; Murray RJ
    Commun Dis Intell Q Rep; 2010 Sep; 34(3):342-4. PubMed ID: 21090191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First report of meningococcal ciprofloxacin resistance in Greece due to invasive isolates of the sequence type ST-3129.
    Tzanakaki G; Georgakopoulou T; Xirogianni A; Papandreou A; Deghmane AE; Magaziotou I; Taha MK
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2467-2470. PubMed ID: 32621148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive meningococcal disease due to ciprofloxacin-resistant Neisseria meningitidis Sequence Type 7926: the first case in Italy, likely imported.
    Vacca P; Vocale C; Fazio C; Ambrosio L; Luzi K; Neri A; Palmieri A; Stefanelli P
    J Glob Antimicrob Resist; 2019 Sep; 18():177-178. PubMed ID: 31325619
    [No Abstract]   [Full Text] [Related]  

  • 12. Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin.
    Hong E; Thulin Hedberg S; Abad R; Fazio C; Enríquez R; Deghmane AE; Jolley KA; Stefanelli P; Unemo M; Vazquez JA; Veyrier FJ; Taha MK
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1961-4. PubMed ID: 23357770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of resistance to ciprofloxacin in Neisseria meningitidis in Brazil.
    Gorla MC; Cassiolato AP; Pinhata JMW; de Moraes C; Corso A; Gagetti P; Lemos AP
    J Med Microbiol; 2018 Mar; 67(3):286-288. PubMed ID: 29458676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of MDR invasive Neisseria meningitidis in El Salvador, 2017-19.
    Marín JEO; Villatoro E; Luna MJ; Barrientos AM; Mendoza E; Lemos APS; Camargo CH; Sacchi CT; Cunha MPV; Galas M; Gabastou JM
    J Antimicrob Chemother; 2021 Apr; 76(5):1155-1159. PubMed ID: 33517418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of ciprofloxacin-resistant
    Juscamayta-López E; Valdivia F; Morales S; Donaires LF; Fiestas-Solórzano V; Oré M; Pachas P; León-Janampa N; Gavilán R
    J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33196407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review and meta-analysis on the antibiotic resistance of Neisseria meningitidis in the last 20 years in the world.
    Rostamian M; Chegene Lorestani R; Jafari S; Mansouri R; Rezaeian S; Ghadiri K; Akya A
    Indian J Med Microbiol; 2022; 40(3):323-329. PubMed ID: 35654713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotics for preventing meningococcal infections.
    Fraser A; Gafter-Gvili A; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2006 Oct; (4):CD004785. PubMed ID: 17054214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical aspects and outcome of meningococcal disease due to Neisseria meningitidis of serogroup W135 in 5 children].
    Faye A; Mariani-Kurkjian P; Taha MK; Louzeau C; Bingen E; Bourrillon A
    Arch Pediatr; 2005 Mar; 12(3):291-4. PubMed ID: 15734127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary meningococcal conjuctivitis with the development of a systemic disease].
    Petrousová L; Roznovský L
    Klin Mikrobiol Infekc Lek; 2013 Sep; 19(3):107-8. PubMed ID: 24579454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotics for preventing meningococcal infections.
    Fraser A; Gafter-Gvili A; Paul M; Leibovici L
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004785. PubMed ID: 15674966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.